Ocular Therapeutix, Inc. - stock earnings
OCUL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -29.2 million USD | 14.8 million USD |
| 2023Q3 | -516000 USD | 15.0 million USD |
| 2023Q2 | -20.7 million USD | 15.2 million USD |
| 2023Q1 | -36.4 million USD | 13.4 million USD |
| 2022Q4 | -11.7 million USD | 14.1 million USD |
| 2022Q3 | -26.8 million USD | 12.0 million USD |
| 2022Q2 | -17.6 million USD | 12.3 million USD |
| 2022Q1 | -7.3 million USD | 13.2 million USD |
| 2021Q4 | -5.5 million USD | 12.3 million USD |
| 2021Q3 | 2.7 million USD | 12.2 million USD |
| 2021Q2 | -8.5 million USD | 11.7 million USD |
| 2021Q1 | 3.1 million USD | 7.3 million USD |
| 2020Q4 | -85.6 million USD | 7.3 million USD |
| 2020Q3 | -11.9 million USD | 5.9 million USD |
| 2020Q2 | -36.6 million USD | 1.6 million USD |
| 2020Q1 | -21.5 million USD | 2.6 million USD |
| 2019Q4 | -26.0 million USD | 2.3 million USD |
| 2019Q3 | -18.8 million USD | 829000 USD |
| 2019Q2 | -24.5 million USD | 650000 USD |
| 2019Q1 | -17.1 million USD | 492000 USD |
| 2018Q4 | -17.4 million USD | 504000 USD |
| 2018Q3 | -15.0 million USD | 498000 USD |
| 2018Q2 | -13.8 million USD | 648000 USD |
| 2018Q1 | -13.8 million USD | 340000 USD |
| 2017Q4 | -13.1 million USD | 487000 USD |
| 2017Q3 | -15.6 million USD | 523000 USD |
| 2017Q2 | -18.7 million USD | 438000 USD |
| 2017Q1 | -16.0 million USD | 475000 USD |
| 2016Q4 | -12.8 million USD | 511000 USD |
| 2016Q3 | -9.6 million USD | 477000 USD |
| 2016Q2 | -11.4 million USD | 441000 USD |
| 2016Q1 | -10.8 million USD | 458000 USD |
| 2015Q4 | -10.6 million USD | 436000 USD |
| 2015Q3 | -11.5 million USD | 429000 USD |
| 2015Q2 | -10.0 million USD | 459000 USD |
| 2015Q1 | -7.6 million USD | 426000 USD |
| 2014Q4 | -8.0 million USD | 505000 USD |
| 2014Q3 | -7.3 million USD | 143000 USD |
| 2014Q2 | -6.4 million USD | 97000 USD |
| 2014Q1 | -7.0 million USD | 27000 USD |
| 2013Q4 | -3.5 million USD | ? USD |
| 2013Q3 | -3.5 million USD | ? USD |
| 2013Q2 | -3.1 million USD | ? USD |
| 2013Q1 | -3.2 million USD | ? USD |
| 2012Q4 | ? USD | 10000 USD |
OCUL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -80.7 million USD | 58.4 million USD |
| 2022 | -63.4 million USD | 51.5 million USD |
| 2021 | -10.8 million USD | 43.5 million USD |
| 2020 | -159.6 million USD | 17.4 million USD |
| 2019 | -89.9 million USD | 4.2 million USD |
| 2018 | -57.7 million USD | 2.0 million USD |
| 2017 | -63.4 million USD | 1.9 million USD |
| 2016 | -44.7 million USD | 1.9 million USD |
| 2015 | -39.7 million USD | 1.8 million USD |
| 2014 | -28.6 million USD | 772000 USD |
| 2013 | -13.3 million USD | ? USD |
| 2012 | -14.1 million USD | 10000 USD |
OCUL
Price: $6.26
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.01 USD
P/E Ratio: -5.56
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 567800
Ebitda: -14.6 millionMarket Capitalization: 1.4 billion